Ulcerative Colitis: Thiéfin G

 Topic:  
Hints · Remembered Topics    
  Start Here  Overview  World Articles  Find Experts  Books & DVDs  Help 
 
Column View Map 5 Articles   Help
A digest of articles written 1999 and later, on the topic "Colitis, Ulcerative," originating from Planet Earth —» Thiéfin G.  Display:  All Citations ·  All Abstracts
1 Review Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. 2005

Thiéfin G, Beaugerie L. · Hepatogastroenterology Department, Robert Debré Teaching Hospital, Reims, France. · Joint Bone Spine. · Pubmed #16038840 No free full text.

Abstract: The gastrointestinal toxicity of conventional nonsteroidal antiinflammatory drugs (NSAIDs) is not confined to the stomach and proximal duodenum but extends also to the rest of the small bowel, colon, and rectum. Long-term NSAID therapy usually induces clinically silent enteropathy characterized by increased intestinal permeability and inflammation. Chronic occult bleeding and protein loss may result in iron-deficiency anemia and hypoalbuminemia. NSAIDs can also induce small bowel ulcers that infrequently lead to acute bleeding, perforation, or chronic scarring responsible for diaphragm-like strictures. At the colon and rectum, NSAID use can result in de novo lesions such as nonspecific colitis and rectitis, ulcers, and diaphragm-like strictures. NSAIDs have been implicated in the development of segmental ischemic colitis. In patients with diverticular disease, NSAID use increases the risk of severe diverticular infection and perforation. NSAIDs can trigger exacerbations of ulcerative colitis or Crohn's disease. With selective COX-2 inhibitors, the risk of gastrointestinal toxicity is reduced as compared to conventional NSAIDs but is not completely eliminated. Experimental studies suggest that long-term COX-2 inhibitor therapy may cause damage to the previously healthy small bowel. Similar to conventional NSAIDs, COX-2 inhibitors may be capable of triggering exacerbations of inflammatory bowel disease.

2 Article Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey. free! 2006

Bensoussan M, Jovenin N, Garcia B, Vandromme L, Jolly D, Bouché O, Thiéfin G, Cadiot G. · Service d'Hépato-Gastroentérologie, Hôpital Robert Debré, Reims. · Gastroenterol Clin Biol. · Pubmed #16514377 links to  free full text

Abstract: AIMS: Thirty to 50% of north American patients with inflammatory bowel disease (IBD) have been reported to use complementary and alternative medicine (CAM). There is no data in France. The aim of this study was to evaluate the frequency of CAM use and the reasons in a French population of patients with IBD. PATIENTS AND METHODS: An anonymous postal survey was done with a questionnaire mailed to all the patients with IBD, 16 to 79 year-old, followed-up in a public and a private medical centre of Reims, between January 2001 and December 2003. RESULTS: The final sample included 447 patients; 325 (72.7%) filled up the questionnaire: 219 (67.4%) had Crohn's disease, 94 (28.8%) ulcerative colitis and 12 (3.7%) indeterminate colitis. Sixty-nine patients (21.2%) reported CAM use for IBD. The mean number of CAM used simultaneously was 2.9. The most frequently used CAM treatment was homeopathy (40.6%), followed by magnetism (34.8%) and acupuncture (33.3%). The majority of patients (74.8%) never talked about CAM use with their IBD physician. Multivariate analysis showed that the factors significantly associated with CAM use were female gender (odds ratio (OR)=3.5, CI95%: 1.8-6.9), the low level of confidence in their doctor (OR=4.8, CI95%: 1.1-19.8) and the research of informations about their disease (OR=4.6, CI 95%: 2.0-10.7). CONCLUSION: Twenty-one percent of patients with IBD are using CAM, most of the time without talking about it with their physician. The quality of the relationship between the patient and his physician and female sex, more than the perceived severity of the disease, were the main determinants of that use.

3 Article [Diclofenac-induced colitis complicated by Klebsiella oxytoca infection] 2001

Soussi F, Tchirikhtchian K, Ramaholimihaso F, Yaziji N, Coussinet S, Diebold MD, Cadiot G, Thiéfin G. · Service d'Hépato-Gastroentérologie, Hôpital Robert-Debré, CHU, Reims, France. · Gastroenterol Clin Biol. · Pubmed #11598543 No free full text.

Abstract: A 25-year-old man presented with abdominal pain and bloody diarrhea. Colonoscopy showed hemorrhagic proctocolitis with superficial erosions. Histology was consistent with the diagnosis of ulcerative colitis and biopsy cultures were negative. Despite treatment with prednisolone (40 mg/day), his clinical condition deteriorated and he was referred to our institution. On repeated questioning, the patient reported self-medication with diclofenac (200 mg/day) for 6 weeks to treat tendinitis prior to the beginning of digestive symptoms. Rectosigmoidoscopy confirmed bleeding colitis and repeated biopsy cultures showed Klebsiella oxytoca. Corticosteroids were stopped and ofloxacin (400 mg/day) was prescribed for 14 days. Diarrhea quickly resolved. Colonoscopy 8 weeks later showed only patchy erythematous mucosa without bleeding or erosions. Two years later, the patient remains asymptomatic with normal total colonoscopy. The definitive diagnosis was de novo NSAID-induced colitis subsequently complicated by Klebsiella oxytoca infection.

4 Article [Protective effect of appendectomy on the development of ulcerative colitis. A case-control study] 2001

Uzan A, Jolly D, Berger E, Diebold MD, Geoffroy P, Renard P, Vandromme L, Bourgeois L, Ramaholimihaso F, Bouché O, Zeitoun P, Cadiot G, Thiéfin G. · Service d'Hépato-Gastroentérologie, CHU Robert-Debré, Reims. · Gastroenterol Clin Biol. · Pubmed #11395669 No free full text.

Abstract: AIMS: To examine by a case-control study the relationship between appendectomy and subsequent ulcerative colitis development in a French population.METHODS: A total of 150 patients with ulcerative colitis were matched for age (+/- 5 years) and sex, with 150 controls recruited in a preventive medicine center. The following data were collected from medical records and by standardised questionnaire in consultation or by phone: appendectomy and tonsillectomy before the onset of ulcerative colitis, smoking habits and area of residence.RESULTS: The rate of previous appendectomy in patients with ulcerative colitis was 8% (12/150) compared with 30.6% (46/150) in the control group (P=0.001). There was no significant association between ulcerative colitis and tonsillectomy (25.3 and 27.3% in the control and the ulcerative colitis groups, respectively). Smoking was more frequent in the control group (36%) than in the ulcerative colitis group (25.3%) but the difference was not significant (P=0.07). In multivariate analysis, the risk of developing ulcerative colitis was significantly lower after previous appendectomy (odds ratio=0.26; 95% confidence interval: 0.13-0.55; P=7 x 10(-4)).CONCLUSION: Our study confirms the inverse association between appendectomy and subsequent ulcerative colitis, in a French population, after adjusting on smoking.

5 Minor [Systemic sclerosis and ulcerative colitis] 2001

Moncoucy X, Hamon R, Diebold MD, Coussinet S, Pennaforte JL, Thiéfin G, Cadiot G. · No affiliation provided · Gastroenterol Clin Biol. · Pubmed #11395683 No free full text.

This publication has no abstract.